Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Proportion of cancer in a Middle eastern country attributable to established risk factors.

Charafeddine MA, Olson SH, Mukherji D, Temraz SN, Abou-Alfa GK, Shamseddine AI.

BMC Cancer. 2017 May 18;17(1):337. doi: 10.1186/s12885-017-3304-7.

2.

Translating the WHO 25×25 goals into a UK context: the PROMISE modelling study.

Cobiac LJ, Scarborough P.

BMJ Open. 2017 Apr 4;7(4):e012805. doi: 10.1136/bmjopen-2016-012805.

3.

Lung cancer and tobacco smoking in Crete, Greece: reflections from a population-based cancer registry from 1992 to 2013.

Sifaki-Pistolla D, Lionis C, Georgoulias V, Kyriakidis P, Koinis F, Aggelaki S, Tzanakis N.

Tob Induc Dis. 2017 Jan 19;15:6. doi: 10.1186/s12971-017-0114-2. eCollection 2017.

4.

Cancer incidence attributable to tobacco in Alberta, Canada, in 2012.

Poirier AE, Grundy A, Khandwala F, Tamminen S, Friedenreich CM, Brenner DR.

CMAJ Open. 2016 Oct 13;4(4):E578-E587. doi: 10.9778/cmajo.20150069. eCollection 2016 Oct-Dec.

5.

Hepatocellular carcinoma: a review.

Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP Jr.

J Hepatocell Carcinoma. 2016 Oct 5;3:41-53. eCollection 2016. Review.

6.

Electronic Cigarette: Role in the Primary Prevention of Oral Cavity Cancer.

Franco T, Trapasso S, Puzzo L, Allegra E.

Clin Med Insights Ear Nose Throat. 2016 Oct 17;9:7-12. eCollection 2016.

7.

Risk factors for cancer development in type 2 diabetes: A retrospective case-control study.

Dąbrowski M, Szymańska-Garbacz E, Miszczyszyn Z, Dereziński T, Czupryniak L.

BMC Cancer. 2016 Oct 10;16(1):785.

8.

High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.

Squillace N, Galli L, Bandera A, Castagna A, Madeddu G, Caramello P, Antinori A, Cattelan A, Maggiolo F, Cingolani A, Gori A, Monforte Ad; ICONA Foundation Study Group..

Medicine (Baltimore). 2016 Sep;95(36):e4434. doi: 10.1097/MD.0000000000004434.

9.

Hepatocellular carcinoma: epidemiology and risk factors.

Kew MC.

J Hepatocell Carcinoma. 2014 Aug 13;1:115-25. doi: 10.2147/JHC.S44381. eCollection 2014. Review.

10.

Helping patients to reduce tobacco consumption in oncology: a narrative review.

Lucchiari C, Masiero M, Botturi A, Pravettoni G.

Springerplus. 2016 Jul 20;5(1):1136. doi: 10.1186/s40064-016-2798-9. eCollection 2016. Review.

11.
12.

Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.

Thein HH, Qiao Y, Young SK, Zarin W, Yoshida EM, de Oliveira C, Earle CC.

Curr Oncol. 2016 Jun;23(3):e196-220. doi: 10.3747/co.23.2956. Epub 2016 Jun 9.

13.

Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.

Aizawa K, Liu C, Tang S, Veeramachaneni S, Hu KQ, Smith DE, Wang XD.

Int J Cancer. 2016 Sep 1;139(5):1171-81. doi: 10.1002/ijc.30161. Epub 2016 May 14.

PMID:
27116542
14.

Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium.

Ordóñez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, O'Doherty MG, Scott A, Kee F, Stricker BH, Hofman A, de Keyser CE, Ruiter R, Söderberg S, Jousilahti P, Kuulasmaa K, Freedman ND, Wilsgaard T, de Groot LC, Kampman E, Håkansson N, Orsini N, Wolk A, Nilsson LM, Tjønneland A, Pająk A, Malyutina S, Kubínová R, Tamosiunas A, Bobak M, Katsoulis M, Orfanos P, Boffetta P, Trichopoulou A, Brenner H; Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES)..

BMC Med. 2016 Apr 5;14:62. doi: 10.1186/s12916-016-0607-5.

15.

Shared Risk Factors in Cardiovascular Disease and Cancer.

Koene RJ, Prizment AE, Blaes A, Konety SH.

Circulation. 2016 Mar 15;133(11):1104-14. doi: 10.1161/CIRCULATIONAHA.115.020406. Review.

16.

Tobacco smoking and the risk of gallbladder disease.

Aune D, Vatten LJ, Boffetta P.

Eur J Epidemiol. 2016 Jul;31(7):643-53. doi: 10.1007/s10654-016-0124-z. Epub 2016 Feb 22.

17.

Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada.

Saint-Jacques N, Lee JS, Brown P, Stafford J, Parker L, Dummer TJ.

BMC Public Health. 2016 Feb 19;16:175. doi: 10.1186/s12889-016-2767-9.

18.
19.

Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome.

Lee JS, Ahn JY, Choi KD, Song HJ, Kim YH, Lee GH, Jung HY, Ryu JS, Kim SB, Kim JH, Park SI, Cho KJ, Kim JH.

Korean J Intern Med. 2016 Mar;31(2):253-9. doi: 10.3904/kjim.2014.182. Epub 2016 Feb 11.

20.

Impact of smoking on mortality of patients with non-small cell lung cancer.

Lee SJ, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, Yoo CG, Han SK, Kim YW.

Thorac Cancer. 2014 Jan;5(1):43-9. doi: 10.1111/1759-7714.12051. Epub 2014 Jan 2.

Supplemental Content

Support Center